D

C

DUTRIAUX , C.

Last name: DUTRIAUX

First name: C.

December 30, 2020 (v1)

Journal article

Metadata-only

Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆

Di Filippo, Y. Dalle, S. Mortier, L.

Background: The 'obesity paradox' suggests that higher body mass index (BMI) is associated with better survival values in metastatic melanoma patients, especially those receiving targeted and immune checkpoint inhibitor therapy. Higher BMI is also associated with higher incidences of treatment-related adverse events (TRAEs). This study assesses...

Uploaded on: December 4, 2022
March 2024 (v1)

Journal article

Metadata-only

The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns

Amini-Adle, M. Arnault, J.-P. Aubin, F.

International audience

Uploaded on: October 24, 2024